Wylam Faught
Overview
Explore the profile of Wylam Faught including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
342
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cooke C, Babadagli M, Wilson H, Nair V, Lupe K, Malone S, et al.
Curr Oncol
. 2024 Dec;
31(12):7575-7585.
PMID: 39727681
(1) Background: The objectives of this study were to assess survival of patients with a diagnosis of brain metastases secondary to gynaecologic malignancy and the impact of clinicopathological factors on...
2.
Burgess L, AlDuwaisan W, Zhang T, Lupe K, Fung-Kee-Fung M, Faught W, et al.
Curr Oncol
. 2022 Dec;
29(12):9525-9534.
PMID: 36547162
The standard of care for early-stage cervix cancer is radical hysterectomy with pelvic lymphadenectomy. Adjuvant radiotherapy (RT) or chemoradiotherapy may be administered to reduce the risk of recurrence in patients...
3.
Bernard L, Fearon D, McFaul S, Faught W
Int J Gynecol Cancer
. 2019 Nov;
30(1):29-34.
PMID: 31780566
Introduction: The elimination of cervical cancer will only be achievable through primary and secondary prevention. The aim of this study was to determine the effect of primary care enrolment on...
4.
Faught W, Gill R, Ng-Kamstra J
J Obstet Gynaecol Can
. 2015 Nov;
37(10):894-6.
PMID: 26606703
No abstract available.
5.
Le T, Latifah H, Jolicoeur L, Faught W, Weberpals J, Hopkins L, et al.
Int J Gynecol Cancer
. 2011 Mar;
21(5):811-5.
PMID: 21412160
Objective: To determine the prevalence of grade 3 or 4 toxicity associated with intraperitoneal (IP) chemotherapy subsequent to primary surgical debulking compared to post-neoadjuvant chemotherapy and interval debulking in advanced...
6.
Eiriksson L, Cuartero J, Steed H, Pearcey R, Capstick V, Schepansky A, et al.
Int J Gynecol Cancer
. 2010 Nov;
20(8):1356-62.
PMID: 21051977
Objective: To examine the efficacy of vaginal vault radiotherapy as adjuvant treatment for patients with high-grade, stage I/II endometrial adenocarcinoma who have been surgically staged. Methods: A retrospective chart review...
7.
El-Messidi A, Morissette C, Faught W, Oppenheimer L
J Obstet Gynaecol Can
. 2010 Nov;
32(8):775-9.
PMID: 21050511
Background: Rising Caesarean section rates have increased rates of abnormally invasive placentation. In the management of such invasive placentation, hysterectomy may result in greater morbidity than more conservative measures. Non-surgical...
8.
Slupsky C, Steed H, Wells T, Dabbs K, Schepansky A, Capstick V, et al.
Clin Cancer Res
. 2010 Oct;
16(23):5835-41.
PMID: 20956617
Purpose: Metabolomics is a new, rapidly expanding field dedicated to the global study of metabolites in biological systems. In this article metabolomics is applied to find urinary biomarkers for breast...
9.
Chamberlain S, Bocking A, McGrath M, Faught W, Liston R, Wilson R, et al.
J Obstet Gynaecol Can
. 2010 Aug;
32(6):539-540.
PMID: 20677393
No abstract available.
10.
Stevinson C, Tonkin K, Capstick V, Schepansky A, Ladha A, Valance J, et al.
J Phys Act Health
. 2009 Jul;
6(3):339-46.
PMID: 19564663
Background: Regular physical activity is associated with quality of life and other health-related outcomes in ovarian cancer survivors, but participation rates are low. This study investigated the determinants of physical...